These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28800384)

  • 1. Exploring conditions for redistribution of anti-tumor necrosis factors to reduce spillage: A study on the quality of anti-tumor necrosis factor home storage.
    de Jong MJ; Pierik MJ; Peters A; Roemers M; Hilhorst V; van Tubergen A
    J Gastroenterol Hepatol; 2018 Feb; 33(2):426-430. PubMed ID: 28800384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The majority of patients do not store their biologic disease-modifying antirheumatic drugs within the recommended temperature range.
    Vlieland ND; Gardarsdottir H; Bouvy ML; Egberts TC; van den Bemt BJ
    Rheumatology (Oxford); 2016 Apr; 55(4):704-9. PubMed ID: 26672907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actual versus recommended storage temperatures of oral anticancer medicines at patients' homes.
    Vlieland ND; van den Bemt B; van Riet-Nales DA; Bouvy ML; Egberts A; Gardarsdottir H
    J Oncol Pharm Pract; 2019 Mar; 25(2):382-389. PubMed ID: 29187027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Inadequate Temperature Storage Conditions on Aggregate and Particle Formation in Drugs Containing Tumor Necrosis Factor-Alpha Inhibitors.
    Vlieland ND; Nejadnik MR; Gardarsdottir H; Romeijn S; Sediq AS; Bouvy ML; Egberts ACG; van den Bemt BJF; Jiskoot W
    Pharm Res; 2018 Feb; 35(2):42. PubMed ID: 29404710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of storage conditions and time on herb of Lonicera macranthoides].
    Ma P; Li LY; Zhang Y
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(6):981-91. PubMed ID: 24956836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quality of storage of thermolabile drugs in patients' homes].
    Cuéllar MJ; Marco JL; Pérez-Castelló I; Castelló Escrivá A
    Rev Calid Asist; 2010; 25(2):64-9. PubMed ID: 19884029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Storage and transport of reconstituted omacetaxine mepesuccinate: Considerations for home administration.
    Parikh A; van de Rijn J; Melville C; Sarkari M; Peltier S; McKean R
    J Oncol Pharm Pract; 2018 Apr; 24(3):201-208. PubMed ID: 29284358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epinephrine doses delivered from auto-injectors stored at excessively high temperatures.
    Rachid O; Simons FE; Rawas-Qalaji M; Lewis S; Simons KJ
    Drug Dev Ind Pharm; 2016 Jan; 42(1):131-135. PubMed ID: 25997362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort.
    Hiroz P; Vavricka SR; Fournier N; Safroneeva E; Pittet V; Rogler G; Schoepfer AM;
    Scand J Gastroenterol; 2014 Oct; 49(10):1207-18. PubMed ID: 25120029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
    Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older Patients' Compliance with Drug Storage Recommendations.
    Vlieland ND; van den Bemt BJF; Bekker CL; Bouvy ML; Egberts TCG; Gardarsdottir H
    Drugs Aging; 2018 Mar; 35(3):233-241. PubMed ID: 29423781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL).
    Kavanaugh A; Mease P
    J Rheumatol Suppl; 2012 Jul; 89():90-3. PubMed ID: 22751603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Hibi T; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):85-95; quiz e14-5. PubMed ID: 23735746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under in-use Conditions with Different Administration Materials.
    Mueller C; Dietel E; Heynen SR; Nalenz H; Goldbach P; Mahler HC; Schmidt J; Grauschopf U; Schoenhamnmer K
    Int J Pharm Compd; 2015; 19(3):261-7. PubMed ID: 26714367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Golimumab in uveitis previously treated with other anti-TNF-alpha drugs: a retrospective study of three cases from a single centre and literature review.
    Calvo-Río V; de la Hera D; Blanco R; Beltrán-Catalán E; Loricera J; Cañal J; Ventosa J; Cifrián JM; Ortiz-Sanjuán F; Rueda-Gotor J; González-Vela MC; González-López M; González-Gay MA
    Clin Exp Rheumatol; 2014; 32(6):864-8. PubMed ID: 25288110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained improvement in health-related quality of life measures in patients with inflammatory bowel disease receiving prolonged anti-tumor necrosis factor therapy.
    Sherman M; Tsynman DN; Kim A; Arora J; Pietras T; Messing S; St Hilaire L; Yoon S; Decross A; Shah A; Saubermann L
    J Dig Dis; 2014 Apr; 15(4):174-9. PubMed ID: 24373601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patients.
    Carter CT; Changolkar AK; Scott McKenzie R
    J Med Econ; 2012; 15(2):332-9. PubMed ID: 22168788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of unused reconstituted bortezomib in original manufacturer vials.
    Vanderloo JP; Pomplun ML; Vermeulen LC; Kolesar JM
    J Oncol Pharm Pract; 2011 Dec; 17(4):400-2. PubMed ID: 20926455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
    Aletaha D; Bingham CO; Tanaka Y; Agarwal P; Kurrasch R; Tak PP; Popik S
    Lancet; 2017 Mar; 389(10075):1206-1217. PubMed ID: 28215362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the sterility, stability, and efficacy of bevacizumab stored in multiple-dose vials for 6 months.
    Chen YH; Wu PC; Shiea J; Lo LH; Wu YC; Kuo HK
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):65-9. PubMed ID: 19232008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.